n(1)-methylnicotinamide has been researched along with Sensitivity and Specificity in 5 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "N1-Methylnicotinamide (NMN) is an endogenous cationic metabolite of nicotinamide (niacine, vitamine PP) whose renal clearance reflects both the capacity of the renal tubular transport system to secrete organic cations and renal plasma flow." | 1.31 | Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. ( Bélaz, N; Biollaz, J; Decosterd, LA; Kesselring, UW; Musfeld, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ladep, NG | 1 |
| Dona, AC | 1 |
| Lewis, MR | 1 |
| Crossey, MM | 1 |
| Lemoine, M | 1 |
| Okeke, E | 1 |
| Shimakawa, Y | 1 |
| Duguru, M | 1 |
| Njai, HF | 1 |
| Fye, HK | 1 |
| Taal, M | 1 |
| Chetwood, J | 1 |
| Kasstan, B | 1 |
| Khan, SA | 1 |
| Garside, DA | 1 |
| Wijeyesekera, A | 1 |
| Thillainayagam, AV | 1 |
| Banwat, E | 1 |
| Thursz, MR | 1 |
| Nicholson, JK | 1 |
| Njie, R | 1 |
| Holmes, E | 1 |
| Taylor-Robinson, SD | 1 |
| Nobuoka, Y | 1 |
| Ogawa, R | 1 |
| Echizen, H | 1 |
| Creeke, PI | 2 |
| Seal, AJ | 2 |
| Dibari, F | 1 |
| Cheung, E | 1 |
| van den Briel, T | 1 |
| Kyroussis, E | 1 |
| Musfeld, C | 1 |
| Biollaz, J | 1 |
| Bélaz, N | 1 |
| Kesselring, UW | 1 |
| Decosterd, LA | 1 |
5 other studies available for n(1)-methylnicotinamide and Sensitivity and Specificity
| Article | Year |
|---|---|
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
Topics: Acetylcarnitine; Adolescent; Adult; Africa, Western; Aged; Aged, 80 and over; alpha-Fetoproteins; Bi | 2014 |
Simultaneous determination of N(1)-methylnicotinamide, L-carnitine, and creatinine in human plasma and urine by liquid chromatography with mass spectrometry for assessing the activities of multiple renal cationic transporters.
Topics: Carnitine; Chromatography, Liquid; Creatinine; Drug Stability; Female; Humans; Male; Mass Spectromet | 2014 |
Quantitation of the niacin metabolites 1-methylnicotinamide and l-methyl-2-pyridone-5-carboxamide in random spot urine samples, by ion-pairing reverse-phase HPLC with UV detection, and the implications for the use of spot urine samples in the assessment o
Topics: Chromatography, High Pressure Liquid; Niacin; Niacinamide; Pyridones; Reproducibility of Results; Se | 2005 |
Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra.
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; NAD; NADP; Niacinamide; Pellagra; Pyridones; S | 2007 |
Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow.
Topics: Biomarkers; Calibration; Cations; Chromatography, High Pressure Liquid; Humans; Ion Transport; Kidne | 2001 |